SharmilanThanendrarajanMD

PubMed

• CLO24-090: Demographics and Outcomes of Autologous Stem Cell Transplant Among IgD Multiple Myeloma Patients.
  Phillip Farmer, Clyde Bailey, Samer Al-Hadidi, Frits VanRhee, Nishanth Thalambedu, Lakshmi Yarlagadda, Sharmilan Thanendrarajan, Maurizio Zangari, Carolina Schinke> ;Journal of the National Comprehensive Cancer Network. 2024 Apr 5
• A Risk Stratification System in Myeloma Patients with Autologous Stem Cell Transplantation.
  Wancheng Guo, Christopher Strouse, David Mery, Eric R Siegel, Manit N Munshi, Timothy Cody Ashby, Yan Cheng, Fumou Sun, Visanu Wanchai, Zijun Zhang, Clyde Bailey, Dais...> ;Cancers. 2024 Mar 11
• Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
  Meera Mohan, Jorge Monge, Nishi Shah, Danny Luan, Mark Forsberg, Vineel Bhatlapenumarthi, Metodi Balev, Anannya Patwari, Heloise Cheruvalath, Divaya Bhutani, Sharmilan...> ;Blood Cancer Journal. 2024 Mar 5
• Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy ...
  Mohan, M., Szabo, A., Patwari, A., Esselmann, J., Patel, T., Bachu, R., Rein, L., Janardan, A., Bhatlapenumarthi, V., Annyapu, E., Skoog, C., Goff, A., Hadidi, S., Rad...> ;Bone Marrow Transplantation. 2024 Feb 15
• Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems.
  Guo, W., Zhan, Y., Mery, D., Siegel, E., Sun, F., Cheng, Y., Ashby, T., Zhang, Z., Bailey, C., Alapat, D., Peng, H., Hadidi, S., Thanendrarajan, S., Schinke, C., Zanga...> ;Blood Cancer Journal. 2024 Feb 14
• 1 citations
  Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth.
  Sun, F., Cheng, Y., Wanchai, V., Guo, W., Mery, D., Xu, H., Gai, D., Siegel, E., Bailey, C., Ashby, C., Al Hadidi, S., Schinke, C., Thanendrarajan, S., Ma, Y., Yi, Q.,...> ;Nature Communications. 2024 Jan 19
• Amyloid Light-Chain (AL) Amyloidosis of the Trachea Associated With an Indolent B-cell Neoplasm.
  Anup Kumar Trikannad, Asis Shrestha, Sruthi Vellanki, Hira I Cheema, Tanvi H Patel, Ramya Bachu, Shobhit Sharma, Susanne K Jeffus, Sharmilan Thanendrarajan> ;Cureus. 2024 Jan 1
• Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up.
  Al Hadidi, S., Bailey, C., Panozzo, S., Cottler-Fox, M., Shaughnessy, J., Zhan, F., van Rhee, F., Thanendrarajan, S., Barlogie, B., Zangari, M., Ababneh, O., Schinke, ...> ;Blood Advances. 2024 Feb 13
• BCMA- and CST6-specific CAR T cells lyse multiple myeloma cells and suppress murine osteolytic lesions.
  Fumou Sun, Yan Cheng, Jin-Ran Chen, Visanu Wanchai, David E Mery, Hongwei Xu, Dongzheng Gai, Samer Al Hadidi, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zang...> ;The Journal of Clinical Investigation. 2024 Jan 2
• 1 citations
  High NEK2 expression in myeloid progenitors suppresses T cell immunity in multiple myeloma.
  Yan Cheng, Fumou Sun, Daisy V Alapat, Visanu Wanchai, David Mery, Wancheng Guo, Huojun Cao, Yuqi Zhu, Cody Ashby, Michael Anton Bauer, Intawat Nookaew, Eric R Siegel, ...> ;Cell Reports. Medicine. 2023 Oct 17
• EDNRA-Expressing Mesenchymal Cells Are Expanded in Myeloma Interstitial Bone Marrow and Associated with Disease Progression.
  Wen Ling, Sarah K Johnson, Syed J Mehdi, Daisy V Alapat, Michael Bauer, Maurizio Zangari, Carolina Schinke, Sharmilan Thanendrarajan, Frits van Rhee, Shmuel Yaccoby> ;Cancers. 2023 Sep 12
• 8 citations
  The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.
  Lindsay Hammons, Aniko Szabo, Abhishek Janardan, Vineel Bhatlapenumarthi, Evanka Annyapu, Binod Dhakal, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Ravi Narra,...> ;Haematologica. 2024 Mar 1
• Under-representation of black patients with multiple myeloma in studies supporting International Myeloma Working Group guidelines.
  Suhib Fahmawi, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy Jr, Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi> ;Journal of Cancer Policy. 2023 Sep 1
• Growth and dormancy control of myeloma cells by mesenchymal stem cells.
  Syed J Mehdi, Kalyan Ghatak, Wen Ling, Sarah K Johnson, Joshua Epstein, Intawat Nookaew, Maurizio Zangari, Carolina Schinke, Sharmilan Thanendrarajan, Frits van Rhee, ...> ;Leukemia Research. 2023 Oct 1
• Necrotizing Enterocolitis in a Patient With Newly Diagnosed Multiple Myeloma and Hyperviscosity Syndrome: A Case Report.
  Tanvi H Patel, Ramya Bachu, Ben Davis, Prashanth Damalcheruvu, Sharmilan Thanendrarajan> ;Cureus. 2023 Jul 1
• 1 citations
  A gene signature can predict risk of MGUS progressing to multiple myeloma.
  Fumou Sun, Yan Cheng, Jun Ying, David Mery, Samer Al Hadidi, Visanu Wanchai, Eric R Siegel, Hongwei Xu, Dongzheng Gai, Timothy Cody Ashby, Clyde Bailey, Jin-Ran Chen, ...> ;Journal of Hematology & Oncology. 2023 Jun 29
• 2 citations
  Concomitant deletion of the short arm (del(1p13.3)) and amplification or gain (1q21) of chromosome 1 by fluorescence in situ hybridization are associated with a poor c...
  Meera Mohan, Zimu Gong, Timothy Cody Ashby, Samer Al Hadidi, Sharmilan Thanendrarajan, Carolina Schinke, Daisy Alapat, John D Shaughnessy Jr, Fenghuang Zhan, Frits van...> ;Cancer. 2023 Aug 15
• Sixth Nerve Palsy From Multiple Myeloma in Central Nervous System: Case Series and Review of Current Literature.
  Nishanth Thalambedu, Prashanth Damalcheruvu, Yetunde Ogunsesan, Tanvi Patel, Ramya Bachu, Trilok Shrivastava, Munawwar Hussain, Jaskirat Sethi, Sharmilan Thanendrarajan> ;Cureus. 2023 Jun 1
• 1 citations
  Variability of definition of high-risk multiple myeloma across phase III clinical trials.
  Faris Jamal Abu Za'nouneh, Obada Ababneh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy Jr, Fenghuang Zhan, Frits van Rhee, Samer Al...> ;Ejhaem. 2023 May 1
• 27 citations
  Risk of infections associated with the use of bispecific antibodies in multiple myeloma: a pooled analysis.
  Farah Mazahreh, Liyan Mazahreh, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy, Fenghuang Zhan, Frits van Rhee, Samer Al Hadidi> ;Blood Advances. 2023 Jul 11
• 1 citations
  Racial Differences in Spinal Cord Compression Related Hospitalizations in Patients with Multiple Myeloma.
  Samer Al Hadidi, Deepa Dongarwar, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, John D Shaughnessy, Frits van Rhee> ;Clinical Hematology International. 2023 Jun 1
• 13 citations
  Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy.
  Al Hadidi, S., Szabo, A., Esselmann, J., Hammons, L., Hussain, M., Ogunsesan, Y., Thalambedu, N., Khan, F., Sethi, J., Janardan, A., Radhakrishnan, S., Thanendrarajan,...> ;Bone Marrow Transplantation. 2023 Apr 1
• 5 citations
  Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience.
  Meera Mohan, Lisa E Rein, Nishanth Thalambedu, Yetunde Ogunsesan, Munawwar Hussain, Jaskirat Sethi, Fatima Khan, Sravani Gundarlapalli, Lakshmi Yarlagadda, Binod Dhaka...> ;American Journal of Hematology. 2022 Dec 1
• 1 citations
  Ethnic Disparities in AL Amyloidosis Outcomes Among Hospitalized Patients in the United States.
  Samer Al Hadidi, Deepa Dongarwar, Hamisu Salihu, Carolina Schinke, Sharmilan Thanendrarajan, Maurizio Zangari, Frits van Rhee> ;Clinical Hematology International. 2022 Sep 1
• 23 citations
  Characterizing the role of the immune microenvironment in multiple myeloma progression at a single-cell level.
  Carolina Schinke, Alexandra M Poos, Michael Bauer, Lukas John, Sarah Johnson, Shayu Deshpande, Luis Carrillo, Daisy Alapat, Leo Rasche, Sharmilan Thanendrarajan, Mauri...> ;Blood Advances. 2022 Nov 22
• Join now to see all

Journal Articles

• Mesenchymal Stem Cells Gene Signature in High‐Risk Myeloma Bone Marrow Linked to Suppression of Distinct IGFBP2‐Expressing Small Adipocytes  
  Bart Barlogie, Sharmilan Thanendrarajan, Carolina Schinke, British Journal of Haematology

Abstracts/Posters

• The Translational Switch of MYC Protein Aliases in Myeloma Tumor Cells
  Sharmilan Thanendrarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Analysis of the Sub-Clonal Structure of Smoldering Myeloma over Time Provides a New Means of Disease Monitoring and Highlights Evolutionary Trajectories Leading to Mye...
  Sharmilan Thanendrarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• EARLY Results of TOTAL Therapy 7 (TT7): High Response Rates of NEWLY Diagnosed High Risk Myeloma to Daratumumab
  Sharmilan Thanendrarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Translational Switch of MYC Protein Aliases in Myeloma Tumor Cells
  Sharmilan Thanendrarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• The Role of PHF19 As a Promoter of Tumorigenicity and Therapeutic Target in Multiple Myeloma
  Sharmilan Thanendrarajan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• Join now to see all

Lectures

• Proliferation and Molecular Risk Score of Low Risk Myeloma Cells Are Increased in High Risk Microenvironment Via Augmented Bioavailability of Growth Factors 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Extracting Prognostic Molecular Information from PET-CT Imaging of Multiple Myeloma Using Radiomic Approaches 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Long-Term Follow-up Identifies Double Hit and Key Mutations As Impacting Progression Free and Overall Survival in Multiple Myeloma 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• The Mutational Landscape of Primary Plasma Cell Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Join now to see all